(Q48821374)

15 February 2018

title

Brain levels of imipramine and desipramine after combined treatment with these drugs in rats (English)

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90082-3

25 January 2024

author name string

A. Jori

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5161343

25 January 2024

D. Bernardi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5161343

25 January 2024

G. Muscettola

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5161343

25 January 2024

S. Garattini

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5161343

25 January 2024

language of work or name

English

0 references

publication date

1 June 1971

1 reference

15 February 2018

full work available at URL

https://api.elsevier.com/content/article/PII:0014299971900823?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90082-3

https://api.elsevier.com/content/article/PII:0014299971900823?httpAccept=text/plain

25 January 2024

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90082-3

European Journal of Pharmacology

25 January 2024

published in

1 reference

15 February 2018

volume

15

1 reference

15 February 2018

page(s)

85-90

1 reference

15 February 2018

issue

1

1 reference

15 February 2018

The metabolism of imipramine and its metabolites by rat liver microsomes

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90082-3

The total fate of a drug: kinetics of distribution, excretion, and formation of 14 metabolites in rats treated with imipramine

25 January 2024

2

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90082-3

Species differences in the plasma protein binding of desipramine

25 January 2024

3

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90082-3

Plasma protein binding of tricyclic anti-depressants in man

25 January 2024

4

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90082-3

Effects of some antidepressant drugs on the depletion of intraneuronal brain catecholamine stores caused by 4,α-dimethyl-meta-tyramine

25 January 2024

6

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90082-3

Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-alpha-ethyl-meta-tyramine

25 January 2024

7

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90082-3

Imipramine metabolism in man. A study of urinary metabolites after administration of radioactive imipramine

25 January 2024

9

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90082-3

Desipramine and amphetamine metabolism.

25 January 2024

10

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90082-3

The effect of imipramine on central monoamine neurons.

25 January 2024

11

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90082-3

SPECIES DIFFERENCES IN THE METABOLISM OF IMIPRAMINE AND DESMETHYLIMIPRAMINE (DMI)

25 January 2024

12

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90082-3

Effect of imipramine, amitriptyline and their monomethyl derivatives on reserpine activity

25 January 2024

14

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90082-3

The Pharmacology of Imipramine and Related Antidepressants

25 January 2024

16

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90082-3

EVALUATION OF DESIPRAMINE IN DEPRESSIVE STATES

25 January 2024

19

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90082-3

An interaction between the antidepressant drugs desipramine and modaline sulphate.

25 January 2024

20

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90082-3

Brain desipramine level in relation to the anti-reserpine acitivity of imipramine.

25 January 2024

21

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90082-3

Mechanism of potentiation of barbiturates and mepbrobamate actions by imipramine

25 January 2024

22

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90082-3

Management of endogenous depressions using psychopharmacologic agents

25 January 2024

24

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90082-3

IMIPRAMINE AND ELECTROSHOCK THRESHOLD

25 January 2024

28

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90082-3

COMBINED ADMINISTRATION OF DESIPRAMINE AND RESERPINE OR TETRABENAZINE IN DEPRESSIVE PATIENTS

25 January 2024

29

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90082-3

The effect of desmethylimipramine and other “anti-tremorine” drugs on the metabolism of tremorine and oxotremorine in rats and mice

25 January 2024

31

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90082-3

On the mechanism of antidepressant action of imipraminelike drugs

25 January 2024

32

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90082-3

Cataleptic state and hypothermia in mice, caused by central cholinergic stimulation and antagonized by anticholinergic and antidepressant drugs

25 January 2024

35

1 reference

https://api.crossref.org/works/10.1016/0014-2999(71)90082-3

25 January 2024

Identifiers

1 reference

15 February 2018

1 reference

15 February 2018